NEWS / PRESS RELEASES
Keep up with the latest.
Official news and announcements from Persist AI.
Press ReleaseFeb 16, 20263 min read
Why Our Partnership with CyanoCapture Excites Me
Persist AI is partnering with CyanoCapture to build the world's first GMP manufacturing platform for delivering peptides and proteins orally through cyanobacteria.
Read article
Press ReleasesJun 14, 20254 min read
Persist AI Welcomes Dr. Amjad Basha Mohammad and Dr. Ramesh Rachapudi to Expand Computational Modeling and Product Development Capabilities
We're excited to continue advancing as an AI-driven pharmaceutical development pioneer by strengthening our computational modeling and product development capabilities.
Read article
Press ReleasesMay 19, 20254 min read
Beyond the $12M: Revolutionizing Drug Formulation Development at Persist AI
We're fundamentally changing how quickly drugs go from molecule to product for patient use. At Persist AI, we're excited to announce our $12M Series A.
Read article
Press ReleasesAug 20, 20242 min read
Persist AI and Nivagen to Collaborate on AI-Driven Manufacturing Process for Long-Acting Injectable
The two companies intend to leverage their complementary expertise and technology to bring a novel long acting injectable and drug product manufacturing platform to market.
Read article
NewslettersAug 16, 20242 min read
Persist AI Raises $4M in Seed Financing to Revolutionize Drug Formulation
Persist AI has successfully raised $4 million in a seed financing round, led by 2048 Ventures with participation from Innospark Ventures, Fellows Fund, Pioneer Fund, Y Combinator, and others.
Read article